1.Research progress of proteomics in biomarkers of pancreatic cancer
International Journal of Surgery 2012;39(6):399-402
This article introduces the proteomic study of the cell lines,tissue,pancreatic juice and serum from well-diagnosed patients of pancreatic cancer,benign pancreatic disease,normal control,etc.The highly specific and sensitive biomarkers and their significant roles in the mechanism of development and progress of pancreatic cancer,early diagnosis,therapy monitoring,prognosis,follow-up,and so on,are presented and discussed.
2.Nutritional therapy on the prognosis of severe acute pancreatitis
International Journal of Surgery 2011;38(8):522-528
Objective To study the effect of enteral nutrition(EN) and total parenteral nutrition(TPN)on patients with severe acute pancreatitis by a Meta analysis.Method s Randomized controlled trials of EN in patients with severe acute pancreatitis were searched in Cochrane library,Pubmed database,CNKI database,CBM database.Data were searched by two statisticians.RevMan 5.0 was applied for statistical analysis.Results Nine randomized controlled trials were enrolled into this analysis.Meta-analysis indicated that the use of enteral nutrition decreased the incidence of infectious complications(RR was 0.37,95% CI[0.18,0.77]),pancreas infectious complications (RR was 0.44,95% CI [0.24,0.81],P < 0.01),MODS (RR was 0.33,95% CI[0.19,0.56]),mortaily (RR was 0.45,95% CI [0.26,0.80]),surgical interventions (RR was 0.51,95% CI [0.36,0.71]).When starting within 48 h of admission,EN,in comparison with TPN,resulted in a statistically significant reduction in the risk of MODS,mortaily and infectious complications.Conclusion For patients with severe acute pancreatitis,early EN therapy is better than TPN.
3.Research progress of serum proteomics technology in biomarkers of pancreatic cancer
International Journal of Surgery 2014;41(3):201-204
Pancreatic cancer is a kind of high degree of malignant gastrointestinal tumor,and its incidence has increased significantly in recent years.Due to the low early diagnosis rate,and the extreme low middile or late resection rate of pancreatic cancer,Pancreatic cancer's prognosis is poor.Therefore,improving the early diagnostic rate of pancreatic cancer has very important significance for improving the prognosis.Early diagnosis of pancreatic cancer is dependent on tumor markers detection to a great extent.And proteomics progress rapidly in recent years and has been widely applied in clinical research.It provides an effective way to find markers.Among all of the spec imens,secrum is easy to obtain,and it allows repetitive detection.What is more,secmm is also renewable.So it is the most ideal for biological specimens.In this review,the proteomics technology role in pancreatic cancer patients serum detection were summarized.
4.Research progress of serum tumor markers in early diagnosis of pancreatic cancer
International Journal of Surgery 2015;42(9):642-645
Pancreatic cancer is one of the malignant tumor with a high case fatality rate.Because the disease onset symptoms is not obvious,and the disease develops quickly, the malignant degree is high, so it is difficult to do early diagnosis in clinical, leading to poor treatment effect.In recent years, more and more of the discovery and application of pancreatic tumor markers provide a new way for early diagnosis of pancreatic cancer.This article is a review of the current status of the research on the tumor markers associated with the early diagnosis of pancreatic cancer.
5.Advances in double negative T cells in tumor immunotherapy
International Journal of Surgery 2015;42(6):422-425
Double negative T cells,namely DNT cells,are specific regulatory cells with TCR+ CD3 + CD4-CD8-in cell phenotype,divide into αβ T cell and γδ T cell,play a very important role in regulating immunoreaction.Previous research restricted to the treatment of autoimmune disease and organ transplantation immunity.Recently dnt cells adoptive immunotherapy,as a new anti-tumor method,gradually come into public view.This review mainly focuses on the source of DNT cells,their anti-tumor effect,as well as the possible mechanism.
6.Analysis of correlation between NKG2D receptor pathway and the mechanism of DNT cell' killing effect
International Journal of Surgery 2015;42(6):429-432
NKG2D is an activating receptor expressed on various immune cells' surfaces.Currently,eight ligands have been found,they can be divided into two kinds:MHC Ⅰ related protein and ULBP molecules.NKG2D receptors and their respective ligands differentially exist in normal and cancerous tissues.So far,many researchers have found that a lot of immune cells' anti-tumor mechanism is mediated by NKG2D receptor and it can't be replaced in the resistance to the development of carcinoma.adoptive immunotherapy is a new method of treating cancer that propose to find tumor-specific cytotoxicity immune cells and enlarge the amount of it,then injected into human body to resist tumor.Recently,many researchers have found that DNT cells (CD4-CD8-T 细胞)have the function of anti-tumor;sadly its mechanisms are unclear.After the summary of NKG2D receptor-mediated pathway of destruction,this paper try to analyze its relevance to DNT cells' killing effect,on the purpose of finding the Killing mechanism of DNT cells that may existed.
7.Progress of immune regulation mechanism of DN Treg cell on immunotherapy
International Journal of Surgery 2012;39(11):777-780
Immune system is the autologous defence system to resist disease.αβ TCR+ CD3+ CD4-CD8-NK1.1-double negative T cell is a special T lymphocyte which has been described in both humans and rodent models.In recent years,the prognosis has been made in the mechanisms by which DN Treg target antigen-specific T cells and tumor cells.DN Treg cells play an important role in immune regulation,immunosuppression,autoimmune and resistance to the host reaction,HIV infection and antitumor.The study mainly introduces the advance of DN Treg cells in immune treatment.
8.Research progress of pancreatic protein tumor markers
International Journal of Surgery 2012;39(8):546-549
Pancreatic cancer is a commonly malignant gastrointestinal tumor with an obviously increasing incidence all over the world.Those patients without specific symptoms at early stage had mostly lost the opportunity of surgical therapy when pancreatic cancer was detected at advanced stage,and their prognosis is poor.Therefore,it is rather crucial to improve the early diagnosis of pancreatic cancer.Tumor marker is a considerable tool for early tumor detection and screening.It will help to improve the diagnostic rate of early pancreatic cancer and promote the prognosis of pancreatic cancer if we could find out tumor markers and screen one or a group of pancreatic cancer tumor markers.
9.Progress of neural invasion in pancreatic cancer
International Journal of Surgery 2013;(2):116-119
Pancreatic cancer is a kind of highly malignant aggressive cancers.Perinearal growth is one of the importcant biological characteristics of pancreatic cancer.Perineural invasion is an independent prognostic indicator of its prognosis.However,the mechanism has not yet completely clear.The pancreatic cancer perineural invasion mechanism research has been the focus of scholars to discuss,however it' s difficult to break through.Therefore,the discussion pancreatic violation of the peripancreatic neural mechanism for early clinical find,early treatment is essential.The mechanisms of pancreatic cancer research,from all kinds of adhesion molecule to the nerve growth factor,related ligand protein path to susceptibility gene expression,have been reported largely,which helps enhance people' s awareness of peripancreatic neural invasion.At the same time,perineural invasion in the early detection of disease,prolonging survival period and improving the quality of life has important significance.Now the progresses of reviews in recent years are discussed as follows.
10.Clinical analysis of 39 cases of pancreatic trauma
International Journal of Surgery 2013;(2):82-85
Objective To explore the key points of diagnosis,treatment and the reasonable surgical methods in 39 cases of pancreas trauma.Methods A retrospective review and analysis the cause and classification of injury,surgical methods of 39 cases of pancreatic trauma in the Department of General Surgery of Affiliated Provinical Hospital of Anhui Medical University during Jan.1990 to Dec.2011.Results In the 39 patients who underwent surgery,38 patients were cured,1 dead duing to craniocerebral injuries,3 patients with complications of pancreatic leakage cured after adequate drainage.Two patients with pancreatic pseudocyst pancreatic pseudocystcyst cured after pancreatic pseudocyst jejunum anastomosis.One patients with traumatic pancreatitis cured after conservative treatment.Conclusions Blunt injury is the most common cause of pancreas trauma.Imaging examination has high value in the early diagnosis of pancreas trauma.The reasonable surgical methods and careful examination during operation can improve the cure rate and reduce the mortality and incidence of complications of pancreatic trauma.If the patient's condition allowed,endoscopy not only contributes to the diagnosis of pancreatic trauma,but is an effective method for treatment of it.